Bank of Montreal
MITO

Bank of Montreal’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

Bank of Montreal’s Portfolio MITO Stock Details MITO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-22
Closed – – 4922
2019
Q4 		$0 Sell
22
-6
-21% -$46 ﹤0.01% 5077
2019
Q3 		$0 Buy
28
+13
+87% +$133 ﹤0.01% 5078
2019
Q2 		$0 Buy
15
+12
+400% +$161 ﹤0.01% 5148
2019
Q1 		$0 Buy
+3
New +$40 ﹤0.01% 4905

Other funds holding MITO

PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PC
PA Capital Richmond, Virginia $142M AUM 46.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of Montreal's MITO Position: Q1 2020 in Review

Bank of Montreal sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q1 2020, closing a stake of 22 shares.

Bank of Montreal first reported a position in MITO in Q1 2019 and held it in 4 quarters. The position peaked at $0 in Q4 2019. 10 funds tracked by Wall St. Rank hold MITO as of Q1 2020.

  • Bank of Montreal reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q1 2020 after selling out during the quarter.
  • Bank of Montreal sold 22 Stealth BioTherapeutics Corp. ADS shares in Q1 2020.
  • Bank of Montreal first reported a position in Stealth BioTherapeutics Corp. ADS in Q1 2019 and held it in 4 quarters.
  • Bank of Montreal's Stealth BioTherapeutics Corp. ADS position peaked at $0 in Q4 2019.
  • 10 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q1 2020.

Based on Bank of Montreal's 13F filing for Q1 2020, filed 13 May 2020.